Occudo Quantitative Strategies’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,071
Closed -$184K 947
2024
Q3
$184K Buy
+20,071
New +$166K 0.03% 596
2023
Q3
Sell
-17,907
Closed -$453K 1301
2023
Q2
$453K Buy
+17,907
New +$451K 0.05% 587
2023
Q1
Sell
-38,672
Closed -$915K 1195
2022
Q4
$915K Sell
38,672
-112,543
-74% -$3.03M 0.11% 311
2022
Q3
$3.83M Buy
151,215
+43,183
+40% +$1.51M 0.3% 65
2022
Q2
$3.59M Buy
+108,032
New +$4.59M 0.29% 73
2022
Q1
Sell
-31,611
Closed -$2.9M 1321
2021
Q4
$2.9M Sell
31,611
-3,034
-9% -$363K 0.26% 92
2021
Q3
$4.39M Buy
34,645
+30,393
+715% +$4.42M 0.53% 10
2021
Q2
$707K Buy
+4,252
New +$689K 0.11% 312

Other funds holding TDOC

Occudo Quantitative Strategies's TDOC Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 20,071 shares — an estimated $184K sold.

Occudo Quantitative Strategies first reported a position in TDOC in Q2 2021 and held it in 8 quarters. The position peaked at $4.39M in Q3 2021. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 20,071 Teladoc Health shares in Q4 2024, an estimated $184K.
  • Occudo Quantitative Strategies first reported a position in Teladoc Health in Q2 2021 and held it in 8 quarters.
  • Occudo Quantitative Strategies's Teladoc Health position peaked at $4.39M in Q3 2021.
  • 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.